Dupilumab had a fivefold improvement in sustained disease remission in bullous pemphigoid compared with placebo, along with a significant reduction in oral corticosteroid use.

Dupilumab significantly reduced airway inflammation in patients with uncontrolled, moderate-to-severe type 2 asthma. Read now.

With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Dupilumab rapidly treated and maintained improvements in lichenification, a type of skin thickening from repetitive ...

Lebrikizumab is comparable or superior to many advanced systemic monotherapies for the short-term treatment of atopic dermatitis.

Abrocitinib was efficacious and safe in patients with atopic dermatitis who did and who did not respond to prior treatment with dupilumab.

Discover a proof-of-concept study that was conducted to explore whether dupilumab could induce desensitisation to peanut.

Dupilumab and tralokinumab treat atopic dermatitis ... Most people can treat their AD with prevention, topical treatments, UV therapy, and by maintaining skin care. Doctors typically wait to ...

"These cytokines appeared to be the key cytokines in defining the disease." When the patient was treated with a dual therapy of two monoclonal antibodies, dupilumab and secukinumab, his symptoms ...

Across six asthma biologics, adherence differed by the therapy given and was often low or irregular based on three adherence measures, according to a presentation here.This cross-sectional cohort ...

Learn how targeted therapy and advanced blood analysis transformed treatment for erthyroderma, a rare inflammatory skin ...